{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:54Z","timestamp":1793731074389,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430024"],"award-info":[{"award-number":["81430024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771124"],"award-info":[{"award-number":["31771124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31271131"],"award-info":[{"award-number":["31271131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871202"],"award-info":[{"award-number":["31871202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Innovative Team of Shandong Province"},{"name":"Taishan Scholars Construction Project, Shandong"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neuropharm.2018.09.042","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T22:08:28Z","timestamp":1539900508000},"page":"291-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced \u03b1-synuclein aggregation"],"prefix":"10.1016","volume":"144","author":[{"given":"Le","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.042_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.06.052","article-title":"Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study","volume":"424","author":"Bharathi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jmri.24644","article-title":"Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study","volume":"41","author":"Blazejewska","year":"2015","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib4","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1471-4159.2001.00060.x","article-title":"Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease","volume":"76","author":"Chinopoulos","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib6","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/molecules17033586","article-title":"Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice","volume":"17","author":"Chu","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg","volume":"40","author":"Ciechanover","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib8","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1074\/jbc.M409946200","article-title":"Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments","volume":"280","author":"Cole","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.intimp.2012.03.012","article-title":"Ocimum gratissimum Linn. and rosmarinic acid, attenuate eosinophilic airway inflammation in an experimental model of respiratory allergy to Blomia tropicalis","volume":"13","author":"Costa","year":"2012","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","article-title":"Oxidative and nitrative protein modifications in Parkinson's disease","volume":"44","author":"Danielson","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1091581810383705","article-title":"Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells","volume":"29","author":"Du","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib14","first-page":"399","article-title":"Iron chelation of rosmarinic acid","volume":"25","author":"Du","year":"2010","journal-title":"Med. J. Qilu"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.freeradbiomed.2015.04.021","article-title":"Rosmarinic acid up-regulates the noise-activated Nrf2\/HO-1 pathway and protects against noise-induced injury in rat cochlea","volume":"85","author":"Fetoni","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","article-title":"Superoxide radical and superoxide dismutases","volume":"64","author":"Fridovich","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.mp.4001937","article-title":"The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element","volume":"12","author":"Friedlich","year":"2007","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib18","series-title":"Potential Sources of Increased Iron in the Substantia Nigra of Parkinsonian Patients","author":"Gerlach","year":"2006"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib19","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","article-title":"Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein","volume":"277","author":"Golts","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/nan.12096","article-title":"Review: iron metabolism and the role of iron in neurodegenerative disorders","volume":"40","author":"Hadzhieva","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib21","first-page":"2695","article-title":"Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells","volume":"9","author":"Han","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.biocel.2013.02.012","article-title":"Role of alpha-synuclein aggregation and the nuclear factor E2-related factor 2\/heme oxygenase-1 pathway in iron-induced neurotoxicity","volume":"45","author":"He","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00702-010-0453-0","article-title":"Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells","volume":"118","author":"He","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","article-title":"Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis","volume":"56","author":"Hirsch","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.etp.2011.01.013","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B","volume":"64","author":"Ito","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib26","doi-asserted-by":"crossref","first-page":"e91641","DOI":"10.1371\/journal.pone.0091641","article-title":"Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice","volume":"9","author":"Jia","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib27","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3109\/13880209.2015.1010738","article-title":"Rosmarinic acid exerts a neuroprotective effect in the kainate rat model of temporal lobe epilepsy: underlying mechanisms","volume":"53","author":"Khamse","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib28","first-page":"502","article-title":"Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management","volume":"5","author":"Kidd","year":"2000","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib29","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1074\/jbc.M709634200","article-title":"Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers","volume":"283","author":"Kostka","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.fct.2010.10.029","article-title":"Astaxanthin protects against MPTP\/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro","volume":"49","author":"Lee","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tox.2008.06.010","article-title":"Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis","volume":"250","author":"Lee","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12640-010-9187-x","article-title":"Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells","volume":"19","author":"Li","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"53 Suppl. l","key":"10.1016\/j.neuropharm.2018.09.042_bib34","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10512","article-title":"Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease","volume":"3","author":"McNaught","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-9422(02)00513-7","article-title":"Rosmarinic acid","volume":"62","author":"Petersen","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12031-009-9182-y","article-title":"Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells","volume":"39","author":"Ren","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(89)90550-8","article-title":"Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP","volume":"101","author":"Rose","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/0929867323666151223094103","article-title":"Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of Parkinson s disease","volume":"23","author":"Segura-Aguilar","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1471-4159.2009.06165.x","article-title":"The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells","volume":"110","author":"Song","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib42","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1128\/AAC.00041-07","article-title":"Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis","volume":"51","author":"Swarup","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/jnc.13180","article-title":"Phenolic compounds prevent the oligomerization of alpha-synuclein and reduce synaptic toxicity","volume":"134","author":"Takahashi","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib45","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.etp.2011.12.005","article-title":"The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis","volume":"65","author":"Venkatachalam","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bcp.2009.03.031","article-title":"Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells","volume":"78","author":"Wang","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12031-011-9693-1","article-title":"Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease","volume":"47","author":"Wang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1254\/jphs.09019FP","article-title":"Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP","volume":"110","author":"Yabe","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib50","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.bbi.2011.05.012","article-title":"Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice","volume":"25","author":"Yang","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2018.09.042_bib51","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","article-title":"Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.09.042_bib52","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.fct.2010.06.036","article-title":"Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related phenolic constituents","volume":"48","author":"Zhang","year":"2010","journal-title":"Food Chem. Toxicol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818307111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818307111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:41:26Z","timestamp":1720708886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818307111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"alternative-id":["S0028390818307111"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.042","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced \u03b1-synuclein aggregation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}